The top five tweets: From Keytruda to cyber-security — what did EPM readers click on this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. Making it in to fifth is the FDA’s approval of Pfizer’s treatment for AML.

4. Cyber-security makes it into our top five at number four.

3. The winner of the RPS Practice Research Award comes in at third for the week.

2. Number two is the technology news from GE Healthcare, which has released a new dry thawing unit.

1. Taking the top position for the week is the story concerning the cessation of Keytruda’s investigational use trials due to safety concerns.